Form 8-K - Current report:
SEC Accession No. 0001999480-25-000024
Filing Date
2025-03-20
Accepted
2025-03-20 16:32:13
Documents
14
Period of Report
2025-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alto-20250317.htm   iXBRL 8-K 28509
2 EX-99.1 exhibit991-earningsrelease.htm EX-99.1 68582
  Complete submission text file 0001999480-25-000024.txt   237094

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alto-20250317.xsd EX-101.SCH 1809
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alto-20250317_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alto-20250317_pre.xml EX-101.PRE 13061
16 EXTRACTED XBRL INSTANCE DOCUMENT alto-20250317_htm.xml XML 2826
Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41944 | Film No.: 25756953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)